Skip to main content
. 2000 May;44(5):1229–1235. doi: 10.1128/aac.44.5.1229-1235.2000

TABLE 2.

Kinetic parameters of the purified IMP-2 enzyme

Substrate Km (μM)ab kcat (s−1)a kcat/Km (μM−1 s−1)
Ampicillin 110 ± 10 (200)c 23 ± 2 (950) 0.21 (4.8)
Carbenicillin 700 ± 65 (NAd) 252 ± 20 (NA) 0.36 (0.02)
Nitrocefin 95 ± 7 (27) 275 ± 22 (63) 2.9 (2.3)
Cephaloridine 3 ± 0.2 (22) 0.8 ± 0.06 (53) 0.27 (2.4)
Cefoxitin 7 ± 0.5 (8) 7 ± 0.7 (16) 1.0 (2.0)
Ceftazidime 111 ± 9 (44) 21 ± 2 (8) 0.19 (0.18)
Cefepime 7 ± 0.6 (11) 4 ± 0.2 (7) 0.57 (0.66)
Imipenem 24 ± 2 (39) 22 ± 2 (46) 0.92 (1.2)
Meropenem 0.3 ± 0.03 (10) 1 ± 0.08 (5) 3.3 (0.5)
Aztreonam  NDe  NHf ND
a

Values are means ± standard deviations of three measurements. 

b

Determined as Ki when Km was lower than 10 μM. 

c

Data in parentheses report the corresponding values previously measured for the IMP-1 enzyme (21). 

d

NA, not available. 

e

ND, not determined. 

f

NH, no hydrolysis detected. 

HHS Vulnerability Disclosure